BD Biosciences

CD32

#550586 · flow cytometry

7
Citing papers
114
Combined citations
Supplier page Find this product

Research areas

CAR-T cell therapy research5Monoclonal and Polyclonal Antibodies Research4Cancer Immunotherapy and Biomarkers4Immune Cell Function and Interaction1Inflammasome and immune disorders1MicroRNA in disease regulation1Ocular Diseases and Behçet’s Syndrome1T-cell and B-cell Immunology1

Papers citing this product

1
miR-15a/16 reduces retinal leukostasis through decreased pro-inflammatory signaling
Journal of Neuroinflammation·2016·59 cit.·DOI
2
<i>In vitro</i> elimination of epidermal growth factor receptor‐overexpressing cancer cells by CD32A‐chimeric receptor T cells in combination with cetuximab or panitumumab
International Journal of Cancer·2019·40 cit.·DOI
3
Inhibitory affinity modulation of FcγRIIA ligand binding by glycosphingolipids by inside-out signaling
Cell Reports·2021·8 cit.·DOI
4
CD16-158-valine chimeric receptor T cells overcome the resistance of KRAS-mutated colorectal carcinoma cells to cetuximab
UNC Libraries·2021·3 cit.·DOI
5
CD16-158-Valine Chimeric Receptor T Cells Overcome the Resistance of KRAS-mutated Colorectal Carcinoma Cells to Cetuximab
bioRxiv (Cold Spring Harbor Laboratory)·2019·3 cit.·DOI
6
Antibody-Independent Antitumor Effects of Cd32A-Chimeric Receptor T Cells: Implications for Breast Cancer Prognosis and Treatment
bioRxiv (Cold Spring Harbor Laboratory)·2021·1 cit.·DOI
7
Elimination of Egfr-Overexpressing Cancer Cells by CD32 Chimeric Receptor T Cells in Combination with Cetuximab or Panitumumab
bioRxiv (Cold Spring Harbor Laboratory)·2019·DOI

Similar products

ProductVendorEvidencePricePapers
CD32MouseBD Biosciences——17
CD32MouseBD Biosciences——3
CD32MouseBD Biosciences——2

Rate this reagent

Used this in your lab? Leave a quick rating. Reviews are anonymous and verified by academic email before they appear.

Your email is never shown publicly.